Drug intelligence / Profile preview

ulipristal

Development stage
Approved
Lead developer
Esteve
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Ulipristal is a synthetic selective progesterone receptor modulator (SPRM) used primarily as an emergency contraceptive to prevent pregnancy after unprotected intercourse or contraceptive failure. It acts mainly by inhibiting or delaying ovulation through antagonistic and partial agonist effects at the progesterone receptor, thereby suppressing the luteinizing hormone surge necessary for follicular rupture. Ulipristal may also alter endometrial thickness, potentially affecting implantation, though its primary action is pre-fertilization. It is a derivative of 19-norprogesterone and has some affinity for glucocorticoid receptors but with lower activity than mifepristone. In some regions, it has also been approved for the treatment of uterine fibroids under different brand names[1][3][4][5][6][7].

Brand names
EllaellaOneFibristal
Other names
ulipristal acetate
02

Targets

PR (Progesterone receptor)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on ulipristal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ulipristal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call